Cyclophosphamide and Docetaxel Every 3 Weeks as Neoadjuvant Therapy in Locally Advanced Breast Cancer, A Collaborative Trial.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Cyclophosphamide; Docetaxel
- Indications Advanced breast cancer
- Focus Pharmacogenomic; Therapeutic Use
Most Recent Events
- 12 Dec 2011 Biomarkers information updated
- 08 Dec 2011 Status changed from recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
- 05 Nov 2010 New trial record